Modeling and simulation of organophosphate-induced neurotoxicity: Prediction and validation by experimental studies

Renaud Greget1, Selma Dadak2, Laure Barbier3

  • 1Rhenovia Pharma SAS, Mulhouse, France.

Neurotoxicology
|April 26, 2016
PubMed

Insights

Organophosphorus compounds can cause seizures and brain lesions. A new in silico simulator predicts that combining atropine sulfate and memantine can protect against these neurotoxic effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Computational Biology

Background:

  • Organophosphorus (OP) compounds, including pesticides and chemical warfare agents, are potent cholinesterase inhibitors causing significant health issues like seizures and brain lesions.
  • Developing effective antidotes for OP toxicity is challenging, necessitating innovative approaches like in silico modeling to identify therapeutic targets.

Purpose of the Study:

  • To develop and validate a novel in silico simulator for predicting organophosphorus-induced neurotoxicity.
  • To assess the neuroprotective potential of muscarinic and N-methyl-D-aspartate (NMDA) receptor antagonists against OP compounds.

Main Methods:

  • Development of an in silico simulator to model the effects of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors.
  • Simulation of CA1 hippocampal neuron firing in response to paraoxon (POX) exposure, validated against in vitro patch-clamp data.
  • Experimental validation using in vivo electroencephalography (EEG) in mice exposed to POX, testing atropine sulfate and memantine combinations.

Main Results:

  • The simulator accurately reproduced neuronal firing patterns observed in experimental models of paraoxon intoxication.
  • In silico predictions indicated that atropine sulfate could prevent POX-induced neurotoxicity.
  • A synergistic neuroprotective effect was predicted and experimentally confirmed for the combination of atropine sulfate and memantine.

Conclusions:

  • The developed in silico simulator is a powerful tool for predicting the neurotoxicity of irreversible cholinesterase inhibitors.
  • The combination of muscarinic and NMDA receptor antagonists shows significant promise as a therapeutic strategy against organophosphorus compound-induced central nervous system effects.
  • This computational approach can accelerate the discovery of novel antidotes and treatment strategies for OP poisoning.